Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5885_Библиотеки_им_академика_М_И_Перельмана
.pdf
Index
https://t.me/medicina_free
Proliferating cell nuclear antigen (PCNA), 13
Proliferation, 13, 14, 16, 20, 28, 30, 34,
73–75, 93, 104, 140, 218, 221, 238, 281,
283, 286, 287, 310
Promastigotes, 104, 109–115, 117, 118, 121,
122
Propidium iodide, 75
Prostacyclin, 240
Prostaglandins, 14, 38, 312
Protozoan parasites, 102
Prunella vulgaris ethylacetate fraction
(PVEF), 240
Pseudomonas aeruginosa, 49, 161
Psoriasis, 56, 57, 178, 179
Psoriatic arthritis, 179
Puerarin (PUE), 211
Pulmonary heart disease, 140
Punica granatum, 29, 116
Pyrazol alkaloids, 157
Q
QN-NLC based hydrogel (QN-NLC-Gel),
210, 222
Quality by design (QBD), 120
Quantitative
nanostructure-activity relationships
(QNAR), 262
structure-activity relationship (QSAR), 111
Quantum dots, 186, 189, 256
Quaternization (DQ), 215, 216
Quercetin (QCT), 29, 120, 121, 193, 207,
210, 222, 253, 288–290
Quercitin (QA), 117
Quinoline alkaloids, 107, 108
Quinolones, 108
R
Radical scavenging effects, 118
Radio-imaging agents, 301
Ranunculaceae, 34, 155, 156, 302
Reactive oxygen species (ROS), 14, 16, 18,
30, 72, 120, 122, 236, 238, 239, 253–257,
259, 261, 281, 282
Receptor for advanced glycation end prod-
ucts (RAGE), 51, 165
Redox-active metals, 252
Reducing power (RP), 117
Renal
carcinogenesis, 158
disorders, 136
Response surface methodology (RSM), 89,
93
Resveratrol (RSV), 13, 14, 16, 17, 28, 30,
34, 38, 50, 193, 196, 255, 277, 279–285,
288–291
Reticuloendothelial system (RES), 82, 103,
104
Retinal pigment epithelium, 219
Rheopexy, 217
Rheumatic diseases, 302
Rheumatism, 31, 37, 138
Rheumatoid
arthritis (RA), 2, 3, 14–16, 21, 27–33,
36–38, 178, 179, 222, 233–235,
238–240
celastrol, 20
curcumin, 16
gambogic acid (GA), 20
green tea extract (GTE), 20
herbal pharmacotherapy, 15
hesperidin, 16
resveratrol (RSV), 16
thymoquinone, 15
Tripterygium wilfordii hook F (TWH),
20
disease, 36
factors (RF), 14
Rheumatology, 182
Rhizomes, 30, 43, 45
Right ventricular (RV), 55
Rosmarinic acid, 229–241, 243, 244
angiogenesis inhibitor, 238
anti-cancer agent, 236
anti-depressive agent, 237
anti-hypertensive agent, 240
biosynthesis, 231
cardiomyopathy, 239
chemical nature, 231
pharmacokinetic aspects, 233
pharmacological aspects, 235
photo protective agent, 236
role, 238
significance, 239, 241
variability, 232
Rosmarinus officinalis, 18, 66, 230, 234
S
https://t.me/medicina_free
Salvia officinalis, 18, 234
Scale-up production, 190
Scanning electron microscopy (SEM), 210,
211
Screen macrophages, 28
Scutellarin (SCU), 140, 211
Self-nano emulsifying drug delivery system
(SNEDDS), 52, 312
Self-repair mechanism, 55
Serum
enzymology, 258
glutamate
oxaloacetate transaminase (SGOT),
312
pyruvate transaminase (SGPT), 312
Signaling pathway, 159
Silver-curcumin nanoconjugates
(Ag-CurNCs), 53, 59
Sinomenium acutum, 31, 35
Six framework programme (FP6), 269
Skin disease, 43, 56, 59, 179
Smad signaling pathway, 76
Smallanthus sonchifolius, 112, 113
Sodium arachidonate, 90
Solar spectrum, 236
Solid
dispersions, 142
lipid nanoparticle (SLN), 47, 50, 52, 56,
65, 76, 122, 142, 144, 146, 166, 189,
193, 194, 197, 209, 211, 212, 256, 302,
311, 312, 314
baicalin (BA-SLN), 212
Sphingo-lipids, 142
Squalene cyclization, 66
Staphylococcus aureus, 49, 158, 161, 162
Steroids, 1, 15, 27, 29, 184
Streptozotocin (STZ), 9–11, 19, 163, 167,
304, 310
Styrene-maleic acid (SMA), 50
Sulfur S-methyl cysteine (SMCS), 8
Superoxide dismutase (SOD), 10, 36, 165,
215, 259, 311
Synovial hyperplasia, 31
Synoviocytes, 16, 30
Synthetic drugs, 27, 133, 136, 150, 155,
183, 209, 240
T
Tanacetum parthenium, 110, 113, 115
Tannins, 107, 109, 116, 117
T-cells, 14, 28, 57, 114, 159, 195, 196
activation, 14, 28
Tendonitis, 3
Teratogenicity, 106
Terminalia arjuna, 136, 139, 141
Terpenes, 109
Terpenoids, 1, 27, 29, 107
Testicular
protective activity, 157
tissue, 160, 259
Tetrahydrocurcumin (THC), 13, 51, 52
Tetrandrine-loaded cationic solid lipid
nanoparticles (TET-CNP), 211, 212
Tetrandrineoccular solutions (TET-SOL), 212
Therapeutic
agents, 250, 253, 279, 290, 301, 305
application, 43, 195
carriers, 87
concentrations, 146, 305
drug, 76
effects, 16, 30, 47, 146, 163, 254, 256,
287, 314
endpoints, 146
index, 139, 142, 145, 146, 287, 314
molecules, 55
monitoring, 145
potentials, 48, 51, 55, 92, 156, 171
proteins, 219
strategy, 73
value, 30, 36
Thixotropy, 217
Thymohydroquinone, 157, 158, 171
Thymoquinone (TQ), 15–17, 28–30, 34, 38,
155–168, 170, 171, 301–315
loaded nanostructured lipid carrier
(TQ-NLC), 162, 163, 167
nanoemulsion (TQNE), 165, 307
anticancer activity, 307
antidiabetic activity, 310
anti-inflammatory activity, 311
central nervous system protective
activity, 310
hepatoprotective activity, 312
nanoformulations applications, 313
rich fraction (TQRF), 163, 165
nanoemulsion (TQRFNE), 165
Index
https://t.me/medicina_free
Thyroid gland follicular cell hyperplasia, 254
Tissue
engineering, 76, 87, 88, 201
inhibitor metalloproteinase proteins
(TIMPs), 284
Topoisomerase I (TP-1), 110–112
Total
antioxidant capacity (TAC), 117, 165
oxidative status (TOS), 165
Transcription factor, 76, 88, 159, 257
Transmission electron microscopy, 218
Triatomic isoflavone, 148
Triterpenes, 66, 67, 77, 78, 92, 107
Triterpenoids, 66, 73, 78, 114, 115
Trophoblast, 146, 147
Trypanocidal activity (TPA), 113, 285
Trypterigium wilfordii, 31
Tumor
cells, 47, 48, 70, 116, 159, 281, 305
metastasis, 284
microvasculature, 13
necrosis factor (TNF), 14, 16, 20, 28–32,
49, 53, 109, 158, 179, 180, 193, 261,
311, 312
protein, 16, 17, 30
Tyrosinase enzyme, 56
U
Ultra-deformable liposomes (UDL), 121
Ultrasonic
dispersion, 84
drug, 189
Ultrasonication, 56, 147, 167, 210–212, 309
United Nations (UN), 183
United States-Food and Drug Administra-
tion (US-FDA), 251
Urethrorrhea, 37
Uric acid, 37
Urokinase-type plasminogen (uPA), 195
Ursolic acid (UA), 11, 65–82, 84–86,
88–93, 199, 237
nanoliposomes (UANL), 80, 81
nanoparticles, 73
nanosuspension, 91
niosomes, 90
V
Vascular endothelial growth factor (VEGF),
161, 238, 284
Vasodilation, 140
Vero cells, 110
Viral myocarditis, 140
Visceral leishmaniasis (VL), 101
Vitamin A palmitate (VAP), 215
loaded liposomes (VAPL), 215, 216
Vitex negundo, 31, 35
Vitis vinifera, 16, 17, 30, 141
Volatile oils, 155
W
Walker-256 cells, 12, 17
Wistar rats, 49, 158, 242, 287
World Health Organization (WHO), 2, 3, 7,
102, 133, 183, 209
X
Xenografts, 50, 73, 79, 80
X-ray diffraction, 218
Z
Zeta potential, 47, 53, 57, 112, 118, 161,
163, 211, 212, 214, 215, 218
Zingiber officinale, 138, 199
Соседние файлы в папке Библиотека им академика М.И. Перельмана